Vanderbilt team to test lasso peptides for ovarian cancer
Vanderbilt-Ingram Cancer Center receives a $450,000 grant to develop lasso peptide therapies that enhance immunotherapy response in ovarian cancer.
Vanderbilt-Ingram Cancer Center receives a $450,000 grant to develop lasso peptide therapies that enhance immunotherapy response in ovarian cancer.
Researchers identified two approved drugs that significantly enhance human brown adipocyte activation and differentiation using a data-driven transcriptomic framework.
Researchers developed two naphthoquinone-based probes that selectively detect cyanide in water using cooperative hydrogen bonding, offering a simple and efficient ...
EPFL researchers have engineered a two-layer aptamer sensing architecture that enables visual detection of small molecules by recognizing target-bound DNA ...
Researchers report generating human chemically induced pluripotent stem cells from umbilical cord-derived mesenchymal stem cells using an optimized small-molecule protocol ...
A simplified two-compound drug cocktail, 2SM, promoted cardiomyocyte proliferation and improved heart function after myocardial infarction in rats and mice, ...
A machine-learning pipeline identified AML-selective small molecules and implicated glutathione reductase as a vulnerability that can be exploited in laboratory ...
A new review maps how artificial intelligence is transforming RNA-targeted drug discovery across both small molecules and oligonucleotide therapeutics.
A new neuro-symbolic AI tool called AIMe predicts mass spectra for more than 100 million known small molecules, expanding searchable ...
Researchers have developed a two-step machine-learning method that predicts small-molecule retention times in liquid chromatography for any experimental setup without ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine